Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “adalimumab”

37 pharma patents match "adalimumab" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 37
Index total 30,257
Page 2 / 2

Quick answer

This filtered view shows 37 pharmaceutical patents matching "adalimumab" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

37 results for “adalimumab” · 30,257 patents in full index Clear search

  1. US 9770507

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted

  2. US 9757454

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted

  3. US 9737600

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted

  4. US 9731008

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Aug 15, 2017 · Expires Aug 10, 2037

    granted

  5. US 9731009

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Aug 15, 2017 · Expires Aug 10, 2037

    granted

  6. US 9724415

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted

  7. US 9724414

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted

  8. US 9707293

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  9. US 9682145

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted

  10. US 9382317

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Jul 5, 2016 · Expires Jun 30, 2036

    granted

  11. US 9346880

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted May 24, 2016 · Expires May 19, 2036

    granted

  12. US 9340611

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted May 17, 2016 · Expires May 12, 2036

    granted

  13. US 9340612

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted May 17, 2016 · Expires May 12, 2036

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.